What's breaking now, across thousands of outlets.
Dr. Kalyan noted that bacteriophages selectively target disease-causing bacteria without harming human beings, making them promising alternatives when antibiotics fail
We haven't written up this one. The Hindu - Sci-Tech has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Sales from EU HQ'd vendor rocket in two years. The Trump affect? Yes but NIS2 and DORA are factors too
Biogen is expected to soon release the results of pivotal clinical trials of an experimental therapy for lupus.
Ryugu might have formed in the very first generation of planetary building blocks
Predicted 40 years ago. Never seen... 'til now. Don't miss a story, subscribe here.
In recent trading, shares of Fossil Group Inc (Symbol: FOSL) have crossed above the average analyst 12-month target price of $9.25, changing hands for $9.97/share.
